Sell alert! Why this expert is calling time on Endeavour and A2 Milk shares

A leading analyst forecasts ongoing headwinds for Endeavour and A2 Milk shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It may be time to hit the sell button on Endeavour Group Ltd (ASX: EDV) and A2 Milk Co Ltd (ASX: A2M) shares.

That's according to Dolphin Partners Financial Services' Arthur Garipoli (courtesy of The Bull).

Both S&P/ASX 200 Index (ASX: XJO) stocks have come under renewed selling pressure in 2026.

Recently trading at $5.89 a share, A2 Milk shares are 35.9% year to date.

And shares in Endeavour, which owns and operates liquor outlets, hotels and gaming venues, are down some 16.3% this calendar year.

For some context, the ASX 200 is down 1.5% over this same period.

And looking ahead, Garipoli foresees more headwinds for both beaten down stocks.

Here's why.

Red sell button on an Apple keyboard.

Image source: Getty Images

Time to sell A2 Milk shares?

"This infant milk formula company recently initiated a voluntary recall of three small batches of product sold in the United States," Garipoli said. "The company announced the recall was isolated to the US label product."

Commenting on the company's 13 April trading update, Garipoli noted:

The shares have remained under pressure since April when the company downgraded guidance in full year 2026. It expects lower infant milk formula sales, mostly related to Chinese labels.

The EBITDA [earnings before interest, taxes, depreciation and amortisation] percentage margin is forecast to decline from previous guidance of between 15.5% to 16% to between 14% to 14.5%.

Investors responded to that news by sending A2 Milk share tumbling 12.0% on the day.

Summarising his sell recommendation on the ASX 200 dairy stock, Garipoli concluded, "Other stocks offer more appealing outlooks. The shares have fallen from $9.24 on April 10 to trade at $6.45 on May 13."

Which brings us to…

Time to exit Endeavour shares?

Atop recommending exiting A2 Milk shares, Garipoli also has a bearish outlook on Endeavour shares.

"Endeavour operates liquor outlets, hotels and gaming facilities," he said.

But despite its leading position in Australia, Garipoli expects Endeavour could struggle over the coming months.

He noted:

While Endeavour is a leader in the liquor retailing space, the business is operating in a challenging economic environment involving fierce competition, continuing margin pressure and macroeconomic shocks. Many analysts have cut forecasts to reflect softer trends.

Then there's the impact of the ongoing Iran conflict.

According to Garipoli:

Increasing fuel costs in response to the Middle East conflict is imposing pricing pressure throughout its supply chain. Increasing cost of living pressures is another challenge. The shares have fallen from $4.04 on March 2 to trade at $3.23 on May 13.

Summarising his sell recommendation on Endeavour shares, he concluded, "Other stocks appeal more in this economic climate of higher interest rates and cash strapped consumers."

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

An oil worker in front of a pumpjack using a tablet.
Broker Notes

Why Woodside shares just got a big buy call

A leading analyst forecasts more outperformance from Woodside’s surging shares.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

Buy, hold, sell: 4DMedical, Cochlear, Westpac shares

An expert discusses his views on Westpac shares and 2 other popular ASX 200 stocks.

Read more »

Woman in business suit holds both hands out with a question mark above each hand.
Broker Notes

Buy, hold, sell: Ampol, Lendlease, BHP shares

Let's check out some new ratings on 3 ASX 200 shares today.

Read more »